News

The American Journal of Managed Care1d
FDA Reviewing Sotatercept-csrk Label Expansion for PAH
Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.
Food Industry Executive3d
Food Exec Brief: M&A Momentum, AI in Food Safety, and the Clean-Label Push
Welcome to the inaugural issue of the Food Exec Brief — our new weekly roundup of key headlines for food manufacturing ...
FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...
Fierce Pharma3d
‘Weak’ evidence and an ‘unpleasant’ odor: FDA sheds light on drug refusal process
When the FDA unexpectedly uploaded around 200 drug rejection letters this week, the regulator provided an in-depth view | ...
Live lobster OK in your carry-on, but don't bring that cast-iron skillet. See TSA list
The Transportation Security Administration has a long list of banned items. Some have conditions and some require you check ...
PharmExec6d
AI’s Realistic Capabilities in FDA’s Approval Process
One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...